Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

McLaren Applied Technologies and the University of Oxford have announced a new partnership that aims to improve the efficiency of patient care and optimise the treatment journey for serious conditions. 

The agreement, which was signed today at McLaren’s headquarters in Woking, will focus on three core areas: 

  • Surgical simulations and outcomes monitoring – creating programmes which advance surgeon training methods, improve patient preparation for surgery and enhance the monitoring of surgery effectiveness.
  • Clinical care optimisation – improving patient care journeys in key need areas, while reducing complications and length of stay in hospital.
  • Facilities optimisation - reviewing the management and allocation of critical medical resources (such as emergency departments) and clinical staff in order to optimise efficiency and availability.

Read more (McLaren Applied Technologies website)

Similar stories

Population-scale study highlights ongoing risk of COVID-19 in some cancer patients despite vaccination

COVID-19 vaccination is effective in most cancer patients, but the level of protection against COVID-19 infection, hospitalisation and death offered by the vaccine is less than in the general population and vaccine effectiveness wanes more quickly.

New reporting guidelines developed to improve AI in healthcare settings

New reporting guidelines, jointly published in Nature Medicine and the BMJ by Oxford researchers, will ensure that early studies on using Artificial Intelligence (AI) to treat real patients will give researchers the information needed to develop AI systems safely and effectively.

Major boost for Oxford’s mission to counter future pandemic threats

The Moh Family Foundation has given a substantial gift to support the work of Oxford University’s Pandemic Sciences Institute, greatly strengthening its ability to identify and counter future pandemic threats and ensure equitable access to treatments and vaccines around the world.

Three NHSBT research units launch at University of Oxford

The NIHR has awarded three new Blood and Transplant Research Units (BTRUs) to the University of Oxford.

Fourth COVID-19 vaccine dose provides stronger immunity boost than third dose, shows UK study

COVID-19 vaccines given as fourth doses in the UK offer excellent boosting immunity protection, according to the latest results from a nationwide NIHR-supported study.